Skip to content
Clinical Trials – home
BulgariaBack to Bulgaria

Clinical trials in Shumen – page 2

26 clinical trials in Shumen, Bulgaria across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

Shumen at a glance
26
clinical trials
  • Paediatric trials0
  • Research sites1
Type of trial
Recruitment status
Quick filters

26 trials in Shumen

Open in trial search

Embolism venous

Not recruiting

Comparison of SRSD107 and enoxaparin to prevent blood clots in adults undergoing knee replacement surgery

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Enoxaparin Sodium
  • Sponsor:Sirius Therapeutics Inc.

Breast cancer+1

Not recruiting

Study of PF-07220060 and Letrozole for Adults with HR-Positive, HER2-Negative Advanced Breast Cancer Without Prior Treatment

Registered drugNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Abemaciclib
  • Sponsor:Pfizer Inc.

Study on Fentanyl Nasal Spray and Morphine for Managing Postoperative Pain in Patients After Surgery

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Fentanyl Citrate
  • Sponsor:5med GmbH

Bladder cancer

Not recruiting

Study on UGN-102 (Mitomycin) for Treating Low Grade Non-Muscle Invasive Bladder Cancer in Patients at Intermediate Risk of Recurrence

InvestigationalNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Mitomycin
  • Sponsor:Urogen Pharma Ltd.

Breast cancer+1

Not recruiting

Study of PF-07220060 and Fulvestrant for Adults with Advanced or Metastatic HR-positive, HER2-negative Breast Cancer After Previous Treatment

Registered drugNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Everolimus
  • Sponsor:Pfizer Inc.

Bladder cancer

Not recruiting

Study on UGN-103 (Mitomycin) for Treating Low Grade Nonmuscle Invasive Bladder Cancer in Patients at Intermediate Risk of Recurrence

InvestigationalNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Poloxamer 407
  • Sponsor:Urogen Pharma Ltd.

Title: Comparison of oral tebipenem pivoxil versus intravenous imipenem-cilastatin in adults with complicated urinary tract infection or acute pyelonephritis

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Cilastatin
  • Sponsor:Spero Therapeutics Inc.

Study Comparing Camizestrant and Palbociclib with Anastrozole and Palbociclib for Patients with ER-Positive, HER2-Negative Advanced Breast Cancer Without Prior Treatment

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:AstraZeneca AB

Cachexia

Not recruiting

Study of ponsegromab for patients with cancer cachexia and elevated GDF-15 levels

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Ponsegromab
  • Sponsor:Pfizer Inc.

Study Comparing RBS-001 and Aflibercept for Patients with Neovascular Age-Related Macular Degeneration

Registered drugNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Aflibercept
  • Sponsor:Rophibio Inc.

Study of Tarlatamab for Patients with Limited-Stage Small-Cell Lung Cancer After Chemoradiotherapy

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Argipressin
  • Sponsor:Amgen Inc.

Study of talazoparib and enzalutamide combination in men with DDR gene mutated metastatic castration-sensitive prostate cancer

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Enzalutamide
  • Sponsor:Pfizer Inc.

Other cities in Bulgaria

The busiest research cities in the country

All 53 cities in Bulgaria

Clinical research in Shumen

What the registry says about research in the country

01 Cardiovascular Research

Innovative studies focusing on heart failure prevention and stroke prevention in patients with atrial fibrillation. Researchers are evaluating novel therapeutic combinations to reduce cardiovascular mortality and improve patient outcomes.

  • Heart Failure Prevention
  • Stroke Prevention
  • Cardiac Disease Management

New treatment approaches combining established medications with experimental compounds show promise in reducing cardiovascular events.

02 Oncology Studies

Comprehensive research into various cancer types, with particular focus on breast cancer and bladder cancer treatments. Multiple trials are investigating targeted therapies for both early-stage and metastatic disease.

  • Breast Cancer Therapeutics
  • Bladder Cancer Treatment
  • Cancer Cachexia Management

Advanced therapeutic approaches including combination treatments and targeted molecular therapies are being evaluated.

03 Neurological Disorders

Groundbreaking research in treating progressive multiple sclerosis, focusing on innovative therapies to slow disease progression and improve patient outcomes. Studies utilize advanced imaging techniques to measure treatment effectiveness.

  • Multiple Sclerosis Treatment
  • Brain Atrophy Assessment
  • Neurological Disease Management

Novel therapeutic approaches are being tested to address progressive forms of MS.

04 Pain Management

Advanced research in postoperative pain management, exploring innovative delivery systems for pain medication. Studies focus on developing more effective pain relief strategies following surgical procedures.

  • Post-Surgery Pain Control
  • Novel Drug Delivery Systems
  • Pain Relief Optimization

Investigations into nasal spray applications for immediate post-surgical pain relief.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.